Home >> Research Area >>Natural Products>>Sesquiterpenoids>> 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

CAS# 16274-33-2

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

Catalog No. BCN1539----Order now to get a substantial discount!

Product Name & Size Price Stock
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 5mg Please Inquire In Stock
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 10mg Please Inquire In Stock
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 20mg Please Inquire Please Inquire
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 50mg Please Inquire Please Inquire
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 100mg Please Inquire Please Inquire
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 200mg Please Inquire Please Inquire
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 500mg Please Inquire Please Inquire
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran: 1000mg Please Inquire Please Inquire

Quality Control of 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

Number of papers citing our products

Chemical structure

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

3D structure

Chemical Properties of 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

Cas No. 16274-33-2 SDF Download SDF
PubChem ID 11052973 Appearance Oil
Formula C15H16O M.Wt 212.3
Type of Compound Sesquiterpenoids Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name 2,2-dimethyl-3,4-dihydrobenzo[h]chromene
SMILES CC1(CCC2=C(O1)C3=CC=CC=C3C=C2)C
Standard InChIKey HYUYQZUDUFSJRS-UHFFFAOYSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

The roots of Galium saxatile.

Biological Activity of 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

In vitro

Identification of a novel glucosylsulfate conjugate as a metabolite of 3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione (ARQ 501, beta-lapachone) in mammals.[Pubmed: 18227145]

Drug Metab Dispos. 2008 Apr;36(4):753-8.


METHODS AND RESULTS:
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione (ARQ 501) is a fully synthetic version of the natural product beta-lapachone, which has been isolated from the lapacho tree (Tabebuia impetiginosa or Tabebuia avellanedae) and has demonstrated promising anticancer activity. 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione formulated with hydroxypropyl-beta-cyclodextrin has successfully completed phase I clinical trials and is currently in several phase II human clinical trials for the treatment of pancreatic cancer, head and neck cancer, and leiomyosarcoma. The metabolites of 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione were investigated by low-resolution and high-resolution mass spectrometry in plasma from (nu/nu) mice, rats, and humans treated with the compound. The data for one of the metabolites identified are consistent with conjugation of 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione with a glucosylsulfate moiety (m/z 241; fragment ion).
CONCLUSIONS:
Although other glucosylsulfate conjugates have been identified as metabolites of pesticides in cotton plants and in crustaceans as phase II metabolites of pyrenes, none have been previously identified in mammals. Data reported here identify a novel metabolic pathway for humans.

Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.[Pubmed: 3652040]

Cancer Res. 1987 Oct 15;47(20):5361-6.

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione (beta-lapachone) is a novel DNA repair inhibitor. 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione was tested for synergistic X-ray-induced lethality in combination with several halogenated pyrimidine radiosensitizers.
METHODS AND RESULTS:
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione synergistically increased the dose enhancement ratios (DERs) of all analogues screened, with the exception of the 2'-chloro derivative of 5-bromodeoxyuridine. 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione had little effect upon the cytotoxicities of unirradiated human epidermoid laryngeal carcinoma cells whether or not they were previously exposed to any of the halogenated pyrimidine radiosensitizers. 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione treatment following X-irradiation of cells that had not incorporated a pyrimidine analogue exhibited DER values of 1.38 +/- 0.05 and 1.40 +/- 0.01 at 10 and 1% survival levels, respectively.
CONCLUSIONS:
3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dioneenhanced the radiosensitization of deoxycytidine analogues to a greater extent than the structurally related deoxyuridine analogues. Greater DERs and lower Do and Dq values were found for deoxycytidine than for deoxyuridine analogue radiosensitizers following 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione treatment.

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 4.7103 mL 23.5516 mL 47.1032 mL 94.2063 mL 117.7579 mL
5 mM 0.9421 mL 4.7103 mL 9.4206 mL 18.8413 mL 23.5516 mL
10 mM 0.471 mL 2.3552 mL 4.7103 mL 9.4206 mL 11.7758 mL
50 mM 0.0942 mL 0.471 mL 0.9421 mL 1.8841 mL 2.3552 mL
100 mM 0.0471 mL 0.2355 mL 0.471 mL 0.9421 mL 1.1776 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

Identification of a novel glucosylsulfate conjugate as a metabolite of 3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione (ARQ 501, beta-lapachone) in mammals.[Pubmed:18227145]

Drug Metab Dispos. 2008 Apr;36(4):753-8.

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran-5,6-dione (ARQ 501) is a fully synthetic version of the natural product beta-lapachone, which has been isolated from the lapacho tree (Tabebuia impetiginosa or Tabebuia avellanedae) and has demonstrated promising anticancer activity. ARQ 501 formulated with hydroxypropyl-beta-cyclodextrin has successfully completed phase I clinical trials and is currently in several phase II human clinical trials for the treatment of pancreatic cancer, head and neck cancer, and leiomyosarcoma. The metabolites of ARQ 501 were investigated by low-resolution and high-resolution mass spectrometry in plasma from (nu/nu) mice, rats, and humans treated with the compound. The data for one of the metabolites identified are consistent with conjugation of ARQ 501 with a glucosylsulfate moiety (m/z 241; fragment ion). Although other glucosylsulfate conjugates have been identified as metabolites of pesticides in cotton plants and in crustaceans as phase II metabolites of pyrenes, none have been previously identified in mammals. Data reported here identify a novel metabolic pathway for humans.

Potentiation of halogenated pyrimidine radiosensitizers in human carcinoma cells by beta-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran- 5,6-dione), a novel DNA repair inhibitor.[Pubmed:3652040]

Cancer Res. 1987 Oct 15;47(20):5361-6.

3,4-Dihydro-2,2-dimethyl-2H-naptho[1,2,-b]pyran-5,6-dione (beta-lapachone) is a novel DNA repair inhibitor. It was tested for synergistic X-ray-induced lethality in combination with several halogenated pyrimidine radiosensitizers. Logarithmic-phase growing human epidermoid laryngeal carcinoma (HEp-2) cells were allowed to incorporate pyrimidine analogues for 48 h (approximately two cell doublings) and then were X-irradiated and subjected to various posttreatments. beta-Lapachone synergistically increased the dose enhancement ratios (DERs) of all analogues screened, with the exception of the 2'-chloro derivative of 5-bromodeoxyuridine. For example, following 5-bromodeoxycytidine sensitization an X-ray DER value of 1.87 +/- 0.04 at 1% survival was increased to 3.51 +/- 0.42 due to a 4-h post-X-irradiation exposure to 4 microM beta-lapachone. Do and Dq values for halogenated pyrimidine-sensitized human epidermoid laryngeal carcinoma cells were decreased 1.4- to 5.4-fold and 1.4- to 4.0-fold, respectively. beta-Lapachone had little effect upon the cytotoxicities of unirradiated human epidermoid laryngeal carcinoma cells whether or not they were previously exposed to any of the halogenated pyrimidine radiosensitizers. beta-Lapachone treatment following X-irradiation of cells that had not incorporated a pyrimidine analogue exhibited DER values of 1.38 +/- 0.05 and 1.40 +/- 0.01 at 10 and 1% survival levels, respectively. beta-Lapachone enhanced the radiosensitization of deoxycytidine analogues to a greater extent than the structurally related deoxyuridine analogues. Greater DERs and lower Do and Dq values were found for deoxycytidine than for deoxyuridine analogue radiosensitizers following beta-lapachone treatment. This agent may improve presently used radiation therapies and enhance proposed strategies which utilize deoxycytidine analogue radiosensitization together with protection of normal tissues by tetrahydrouridine to achieve tumor-selective radiotherapy.

Keywords:

3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran,16274-33-2,Natural Products, buy 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran , 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran supplier , purchase 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran , 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran cost , 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran manufacturer , order 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran , high purity 3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-b]pyran

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: